Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT03289260
Eligibility Criteria:
Inclusion Criteria:
* Ability to understand and willingness to sign and date a written consent document
* Male and female patients \>= 18 years of age
* Negative urine/serum pregnancy test
* Indication for surgical therapy of anal HPV lesions
Exclusion Criteria:
* Participation in another clinical study with experimental therapy
* Diagnosis and therapy of HPV associated lesions in the last 12 months
* Known intolerance of hypersensitivity to Imiquimod
* Women who are pregnant of lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03289260
Study Brief:
Protocol Section:
NCT03289260